Bezlotoxumab during the first episode of Clostridioides difficile infection in patients at high risk of recurrence - Escudero-Sanchez, R.; Ramos-Martínez, A.; Caballero-Bermejo, A.F.; Díaz-Pollán, B.; Ruiz-Carrascoso, G.; Samperio, M.O.; García, P.M.; Amador, P.M.; Romo, F.G.; Segarra, O.M.; Jiménez, G.N.; del Campo Albendea, L.; et al. (European Journal of Clinical Microbiology and Infectious Diseases, 2024)